Luminal A/B breast cancers typically express the estrogen receptor (ER) and progesterone receptor (PR), while Her2-like are typically characterized by overexpression of the human epidermal growth factor receptor (ERBB2, Her2/neu) [2]. This evidence concerns the gene ESR1 and breast carcinoma.